In the context of hTS inhibition and drug resistance studies in the presented work, we directed our interest in the SAINT-Protein delivery system, a variant of the mentioned SAINT-lipid, applied to protein transfection in cancer cells. This evidence concerns the gene APCDD1 and cancer.